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Obesity-induced insulin resistance is associated with low-grade adipose tissue inflammation, but the mech-
anism driving this process remains unclear. In this issue of Cell Metabolism, a study by Deng et al. (2013)
demonstrates a direct immunological role of adipocytes in instigating adipose inflammation via a MHCII-
dependent process.Chronic low-grade inflammation in adi-
pose tissues is widely recognized in
obesity-induced insulin resistance and
its associated metabolic syndromes.
Macrophages are believed to contribute
to this inflammation, as they markedly
infiltrate adipose tissue in obese subjects
(Olefsky and Glass, 2010). In line with the
functional plasticity of these cells,
adipose tissue macrophages (ATMs) in
lean humans and animals are reported to
display an anti-inflammatory (M2-like)
phenotype, whereas those in obese
animals have a proinflammatory (M1-
like) phenotype (Lumeng et al., 2007)
and are the main source of inflammatory
cytokines (e.g., TNF, IL-1b), which in turn
contribute to insulin resistance (Olefsky
and Glass, 2010). While these findings
put macrophages at the center stage of
obesity-induced inflammation and insulin
resistance, they are not the only important
participants, since other immune cells like
neutrophils, T cells, and B cells also infil-
trate adipose tissues during obesity
(Nikolajczyk et al., 2011; Nishimura et al.,
2009; Winer et al., 2011). The exact
mechanism for the development of
obesity-induced adipose tissue inflam-
mation is still not clear, and many ques-
tions are yet to be answered. A study pub-
lished in this issue of Cell Metabolism by
Deng et al. investigates this issue and
sheds new light on the mechanisms initi-
ating obesity-associated inflammation
(Deng et al., 2013).
Although macrophages can activate
T cells, changes in T cells have been re-
ported to precede changes in ATMs
during obesity (Nishimura et al., 2009).
The cause of this initial T cell activation is
unclear. Preadipocytes/adipocytes sharesimilarities with macrophages such as
phagocytosis and upregulation of inflam-
matory genes (e.g., cytokines, MHCII,
and costimulatory molecules) in response
to LPS in vitro (Charrie`re et al., 2003;
Meijer et al., 2011). These observations
raise the question as to whether adipo-
cytes themselves play a direct immuno-
logical role by antigen presentation and
T cell polarization, which may instigate
obesity-induced tissue inflammation.
Major histocompatibility complex II
(MHCII) pathway is crucial to the antigen
presentation process. Antigens pre-
sented on MHCII molecules are recog-
nized by the T cell receptor on CD4+T-
helper (Th) cells and, in conjunction with
costimulatory signals, trigger their polari-
zation to inflammatory Th1, anti-inflam-
matory Th2, or other Th subsets (Th17,
Treg), depending on the cytokine milieu.
Deng et al. performed gene expression
analysis of adipocytes from obese versus
lean women and found a differential upre-
gulation of genes related to the MHCII
pathway, like MHCII genes (e.g., human
leukocyte antigen [HLA]-DMB and -DPB),
and class II transactivator (CIITA), a
regulator of MHCII expression, in obese
tissues (Deng et al., 2013). In line with
this finding, MHCII upregulation was
observed in adipocytes, but not ATMs,
from obese mice following as little as
2–3 weeks of high-fat diet (HFD). The
mechanism of MHCII upregulation in
obese adipocytes was examined next.
Leptin, an adipokine which is upregulated
during obesity, also regulates T cell prolif-
eration and Th1 polarization (Lord et al.,
1998). Studies with differentiated primary
human and mouse 3T3-L1 adipocytes,
as well as leptin-deficient (ob/ob) mice,Cell Metabolismsuggested that adipocyte-derived leptin
stimulated Th1 cells to secrete IFNg,
which induces CIITA and MHCII expres-
sion on adipocytes (Figure 1). In vitro
antigen presentation experiments con-
ducted by coculturing lean versus obese
adipocytes with splenic T cells specific
for MHCII-presented ovalbumin, in the
presence or absence of ovalbumin
(antigen), prompted obese adipocytes
to induce an antigen-specific, MHCII-
dependent CD4+Th1 response. Experi-
ments using CIITA shRNA-transduced
3T3-L1 adipocytes further confirmed the
MHCII dependency of this response.
Similarly, adipocytes from HFD-fed
mice, which had upregulated MHCII,
stimulated increased T cell proliferation.
Finally, WT mice and MHCII-deficient
mice showed similar adiposity on a HFD,
but MHCII deficiency resulted in less
adipose inflammation and insulin resis-
tance when compared to the WT, demon-
strating the in vivo metabolic relevance
of the MHCII-dependent mechanisms in
obesity-associated insulin resistance.
An interesting temporal behavior
emerged from the Deng et al. (2013)
study. MHCII upregulation on adipocytes
was observed as early as 2–3 weeks
following HFD, suggesting that adipocyte
MHCII-mediated activation of Th1 cells
may be an early event in triggering
adipose tissue inflammation (Figure 1).
Following this activation, induction of
cytokine/chemokines may recruit macro-
phages which amplify the tissue in-
flammation. Consistent with this idea,
inflammatory ATMs were noted well after
changes in adipose resident T cells
(ATRs), as late as 12 weeks following
HFD. IL-10 was proposed as a cause of17, March 5, 2013 ª2013 Elsevier Inc. 315
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Figure 1. Adipocytes Play an Active Immunological Role in Orchestrating the Immune-Inflammatory Network in Adipose Tissue during
Obesity
The figure represents some possible interactions between adipocytes, ATMs, ART subsets, and other immune cells which orchestrate chronic low-grade inflam-
mation in the adipose tissue during obesity. During the early phase of obesity (right panel), adipocytes crosstalk with T cells by releasing leptin, which upregulates
Th1 polarization and IFNg production. IFNg induces upregulation of CIITA andMHCII on adipocytes which instigateMHCII-mediated antigen presentation and an
inflammatory Th1 response. Other immune subsets, like CD8+T cells, Th17 cells, and B cells (through antigen presentation to ARTs and pathogenic antibodies),
may contribute to this inflammation. In the later phase of obesity, ATMs are recruited in response to chemokines (e.g., CCL2), and the inflammatory microenvi-
ronment, potentially via IFNg and IL-17, polarizes them to an M1 phenotype. By releasing inflammatory cytokines such as TNF and IL-1b, as well as antigen
presentation to T cells, M1 ATMs further amplify the adipose tissue inflammation, leading to pathogenesis. In contrast, the events during lean conditions are
less understood (left panel). Under lean conditions, Th2 and T-regulatory (Treg) cells dominate the scene. These cells, through the release of IL-4, IL-13, and
IL-10, keep ATMs in anM2 phenotype. M2 ATMs, possibly through the release of anti-inflammatory cytokines, IL-10, and scavenging functions, maintain homeo-
stasis in the adipose tissue. Eosinophil (Eos)-derived IL-4 has been reported to drive M2 polarization of ATM. B cell-derived IL-10 is also suggested to contribute
to this milieu. However, little is known about the immunological role and antigen-presentation capacity of adipocytes themselves during lean phase, although
skewing to Treg or Th2 requires such an interaction, which may come from ATMs as well. [?] indicates possible interactions (or molecules) which are not known
or are currently poorly characterized. Arrows indicate interactions and interacting cytokines involved therein. Possible interactions involving other cell types (e.g.,
NK cells, neutrophils) have not been represented in this simplified figure.
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Previewsthis early lag in ATM activation. Impor-
tantly, adipocytes express low levels of
IL-10 receptor and are unaffected by
IL-10 during the early phase of obesity-
induced inflammation, whereas ATMs
which express this receptor are possibly
prohibited from activating ARTs (via
MHCII) at the early phase. However, the
significance of this initial lag in ATM
response needs further investigation.
An issue that remains to be addressed
is the nature of the antigens presented
by adipocyte MHCII. The authors sug-
gested several possible mechanisms
which could create novel antigens in
obesity—for example, posttranslational
modifications of adipose-derived pro-
teins. Interestingly, some studies report316 Cell Metabolism 17, March 5, 2013 ª201a misbalance of gut microbiota during
obesity (Kim et al., 2012), and it is
possible that gut microbial antigens
that are systemically translocated could
be presented by adipocytes. Further-
more, although phagocytic activities of
preadipocytes have been reported (Char-
rie`re et al., 2003), the ability of adipo-
cytes to internalize, process, and present
antigens via MHCII has yet to be
characterized.
Another point emerging from the
present study is the importance of adap-
tive immunity in regulating obesity-related
inflammation. An increased amount of
CD8+ andCD4+Th1 cells andadecreased
number of CD4+ Th2 and T-regulatory
cells have been observed in HFD-fed3 Elsevier Inc.mice, indicating a skewed T cell response
favoring inflammation (Nikolajczyk et al.,
2011; Nishimura et al., 2009). Interest-
ingly, Th17 cells have also been associ-
ated with obesity and insulin resistance,
and a correlation between percentage of
Th17 cells and BMI has been reported
in type 2 diabetes patients (Nikolajczyk
et al., 2011). In view of the inflammatory
and proangiogenic role of these cells in
other settings, it is possible that Th17
may contribute to adipose tissue inflam-
mation and expansion via angiogenesis
during obesity. In addition to T cells, B
cells also infiltrate adipose tissue early
during diet-induced obesity (Nikolajczyk
et al., 2011; Winer et al., 2011) and are
known to associate with T cells and
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PreviewsATMs surrounding dying adipocytes
(Olefsky and Glass, 2010). B cells, being
antigen-presenting cells, can contribute
to ART activation and to pro- or anti-
inflammatory cytokine production, and
can modulate antibody responses, all of
which may impact the development of
obesity-induced insulin resistance.
Collectively, the Deng et al. study indi-
cates that during obesity, adipocytes
upregulate MHCII and act as antigen-pre-
senting cells to activate a Th1 response,
which is escalated by macrophages to
orchestrate adipose tissue inflammation
(Deng et al., 2013). These findings empha-
size the need to investigate the relative
contribution of different lymphocyte
subsets, ATMs, and adipocytes, as wellas their temporal relationship during
homeostasis or inflammatory skewing in
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The human gut microbiome plays an important role in themetabolism of xenobiotics. In a recent issue ofCell,
Maurice et al. (2013) identify the active members of the gut microbiome and show how gene-expression
profiles change within the gut microbial community in response to antibiotics and host-targeted xenobiotics.Thenumerous anddiversemicrobes in the
gut (the gut microbiota) have long been
known to play key roles in breaking
down otherwise indigestible polysaccha-
rides and protecting the host against
pathogens through enzymatic pathways
encoded for in their microbial genes (the
microbiome) (Blaut, 2011; Sousa et al.,
2008). More recently, the gut microbiome
has been shown to play a role in the
metabolism of xenobiotics including anti-
biotics and drugs targeted against host
physiology: at least 30 commercially avail-
able drugs are metabolized as substrates
by bacterial enzymes (Clayton et al., 2009;
Sousa et al., 2008). The human gut’s
microbial community has been charac-
terized in both healthy and disease
states through 16S ribosomal RNA genesequencing, and Bacteroidetes has been
identified as the most abundant phylum
in most individuals (Clemente et al.,
2012; Human Microbiome Project Con-
sortium, 2012). However, this technique
cannot identify what portion of the gut
microbiome is metabolically active—and
its response to, and role in, xenobiotic
metabolism (Maurice et al., 2013).
To identify the metabolically active
members of the human gut microbiota,
Maurice et al. (2013) subjected fecal
samples to staining with propidium iodide
(Pi), DiBAC, and SybrGreen to identify
cells with a loss of membrane integrity,
membrane polarity, and high or low nu-
cleic acid content, respectively, and then
sorted the cells with FACS. Cells with
high nucleic acid content (HNA), repre-senting metabolically active microbes,
comprised 56.2% of the total (the remain-
ing low nucleic acid content [LNA] frac-
tion was assumed to be inactive). Nearly
a third of the gut microbiota had damage
through the loss of membrane integrity or
membrane polarity. The identity of the
microbes in these fractions was assessed
through 16S rRNA gene sequencing:
the HNA fraction was significantly en-
riched for Firmicutes, specifically Clostri-
diales, and depleted for Bacteroidales,
and the LNA fraction was enriched in
Bifidobacteriales. To confirm that the
gut harbors a distinct subset of metaboli-
cally active Clostridiales, fecal samples
from the same individual at two different
time points were analyzed using meta-
transcriptomics (RNA-seq). Significantly17, March 5, 2013 ª2013 Elsevier Inc. 317
